Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of mepolizumab in hypereosinophilic syndrome.

European annals of allergy and clinical immunology·2026
Same author

High-Flow Nasal Oxygen in the Perioperative Setting: A Narrative Review.

Anaesthesia, critical care & pain medicine·2026
Same author

UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies.

Journal of hematology & oncology·2026
Same author

Transgenerational plasticity responses of larvae of Sydney rock oysters (Saccostrea glomerata) to ocean warming.

Marine pollution bulletin·2025
Same author

Stereotactic Body Radiotherapy for Spinal Oligometastases With or Without Simultaneous Integrated Boost: Results From a Monocentric Retrospective Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency.

IJTLD open·2025
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Allergy and multiple sclerosis: a population-based case-control study.

R Pedotti1, M Farinotti, C Falcone

  • 1Neurological Institute Foundation IRCCS Carlo Besta, Milan, Italy. rpedottie@istituto-besta.it

Multiple Sclerosis (Houndmills, Basingstoke, England)
|August 12, 2009
PubMed
Summary
This summary is machine-generated.

Individuals with a history of atopic allergies, such as allergic asthma, appear to have a reduced risk of developing multiple sclerosis (MS). This suggests a protective effect of T-helper type 2 (Th2) mediated disorders against MS.

More Related Videos

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jun 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Area of Science:

  • Immunology
  • Epidemiology
  • Neurology

Background:

  • Conflicting results exist regarding the association between allergic disorders (T-helper type 2 mediated) and multiple sclerosis (MS), a T-helper type 1/Th17 mediated disease.
  • Understanding this relationship is crucial for elucidating immune response mechanisms in MS pathogenesis.

Purpose of the Study:

  • To investigate the association between a history of allergic disorders and the risk of developing multiple sclerosis.
  • To clarify the potential protective or risk-modifying role of allergies in MS.

Main Methods:

  • A population-based case-control study was conducted in Northern Italy.
  • Telephone interviews were used to gather data from 423 MS cases and 643 population controls.
  • Statistical analysis, including odds ratios and confidence intervals, was performed to assess the association.

Main Results:

  • A history of atopic allergies was associated with a reduced risk of MS (OR, 0.58; 95% CI, 0.38-0.89; P = 0.012).
  • Specifically, allergic asthma showed a significant protective effect (OR = 0.38; 95% CI 0.22-0.66, P < 0.01).
  • No association was observed between MS and nonatopic allergies.

Conclusions:

  • The findings support a protective role for T-helper type 2 (Th2) mediated disorders against the T-helper type 1 (Th1) immune responses implicated in MS.
  • Further research is needed to elucidate the underlying mechanisms linking atopic allergies to modified MS risk.